Metabolic Brain Disease
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.8 | Q2 | 64.9% | 0.995 | Q2 | 83.7% |
| 2024 | 3.5 | Q2 | 65.6% | 0.941 | Q2 | 82.6% |
| 2023 | 3.2 | Q2 | 58.9% | 0.831 | Q2 | 80.9% |
| 2022 | 3.6 | Q2 | 57.3% | 0.761 | Q2 | 79.1% |
| 2021 | 3.7 | Q3 | 49.7% | 0.729 | Q2 | 78.6% |
| 2020 | — | — | 0.851 | Q2 | 81.4% | |
| 2019 | — | — | 0.775 | Q2 | 79.6% | |
| 2018 | — | — | 0.795 | Q2 | 78.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0885-7490
ISSN
1573-7365
country
UScoverage
1986-2026